
Sign up to save your podcasts
Or


Cell and gene therapies; the challenges the insurance industry faces in modeling ultra high cost, novel therapies.
By Society of Actuaries (SOA)4.6
3131 ratings
Cell and gene therapies; the challenges the insurance industry faces in modeling ultra high cost, novel therapies.

78,327 Listeners

32,086 Listeners

30,689 Listeners

25,878 Listeners

4,366 Listeners

1,381 Listeners

1,644 Listeners

112,934 Listeners

56,548 Listeners

9,533 Listeners

15 Listeners

11 Listeners

2 Listeners

2,095 Listeners

1,673 Listeners